Johnson & Johnson COVID-19 Vaccine Isn't As Effective, But Has This Other Big Benefit
Johnson & Johnson COVID-19 Vaccine Isn’t As Effective, But Has This Other Big Benefit 01/29/21 AT 8:59 AM A third COVID-19 vaccine by Johnson & Johnson could be on the horizon, but while it could be beneficial to those who aren’t comfortable with the two doses needed by the Pfizer/BioNTech and Moderna vaccines, there is one major issue with the newest one to potentially hit the market—its efficacy rate. Following global clinical trials, the vaccine was proven to be 66% effective at preventing moderate and severe illness from COVID-19, according to The Washington Post. The trial found 8...